~17 spots leftby Aug 2025

Surgery Techniques for Ulnar Nerve Entrapment

Recruiting in Palo Alto (17 mi)
+8 other locations
KC
Overseen byKevin Chung, MD, MS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Michigan
Disqualifiers: Previous elbow fracture, Recurrent UNE, Carpal Tunnel, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial aims to determine which of two surgeries is more effective in treating ulnar neuropathy at the elbow and reducing symptoms.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment for ulnar nerve entrapment?

Research shows that both simple decompression and anterior transposition are effective treatments for ulnar nerve entrapment at the elbow. Studies indicate that simple decompression can be as effective as anterior transposition, especially for less severe cases, while modified submuscular transposition may be better for more severe cases.12345

Is surgery for ulnar nerve entrapment generally safe?

Research shows that surgeries like simple decompression and anterior transposition for ulnar nerve entrapment are generally safe, with improvements in nerve function observed after surgery. These techniques have been studied in many patients and are considered effective and safe for treating this condition.12345

How does the treatment for ulnar nerve entrapment differ from other treatments?

The treatment for ulnar nerve entrapment, which includes simple decompression and subcutaneous anterior transposition, is unique because it can be performed using minimally invasive techniques, such as endoscopic decompression, which may offer similar effectiveness to more invasive methods. Additionally, for mild cases (grade I), subcutaneous transposition is recommended, while more severe cases (grades II and III) may benefit more from modified submuscular transposition.12678

Research Team

KC

Kevin Chung, MD, MS

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for people with ulnar nerve entrapment at the elbow who have tried non-surgical treatments like night splinting. They must meet specific diagnostic criteria and be able to follow study procedures. It's not for those with previous elbow surgery, other neuropathies, or conditions that make surgery too risky.

Inclusion Criteria

You have a specific nerve condition in your elbow, confirmed by tests that measure the speed of nerve signals and muscle responses.
I have or might have a pinched nerve in my elbow.
Stated willingness to comply with all study procedures and availability for the duration of the study
See 1 more

Exclusion Criteria

My UNE has come back after surgery.
Your ulnar nerve is out of place during the preoperative exam.
I have conditions like Carpal Tunnel Syndrome affecting my nerves.
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery

Participants undergo one of two surgical procedures: subcutaneous anterior transposition or simple decompression

1 day
1 visit (in-person)

Post-Surgery Follow-up

Participants are monitored for recovery and complications at various time points

12 months
Visits at 2 weeks, 6 weeks, 3 months, and 12 months

Treatment Details

Interventions

  • Simple decompression (Procedure)
  • Subcutaneous anterior transposition (Procedure)
Trial OverviewThe study compares two surgeries: 'simple decompression' and 'subcutaneous anterior transposition,' to see which one better relieves symptoms of ulnar neuropathy at the elbow. Participants will be randomly assigned to one of these surgical options.
Participant Groups
2Treatment groups
Active Control
Group I: Subcutaneous anterior transpositionActive Control1 Intervention
Anterior transposition repositions the ulnar nerve, providing decompression and lengthening by moving the nerve anterior to the axis of elbow rotation
Group II: Simple decompressionActive Control1 Intervention
In-situ decompression releases only the compressive ligamentous structures overlying the ulnar nerve.

Simple decompression is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Ulnar Nerve Release for:
  • Ulnar neuropathy at the elbow (UNE)
  • Cubital tunnel syndrome

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

Marschall S. Runge

University of Michigan

Chief Executive Officer since 2015

MD, PhD

Karen McConnell profile image

Karen McConnell

University of Michigan

Chief Medical Officer since 2020

MD

University of Oklahoma

Collaborator

Trials
484
Recruited
95,900+
Dr. Scott Rollins profile image

Dr. Scott Rollins

University of Oklahoma

Chief Executive Officer since 2016

PhD in Immunology from the University of Oklahoma

Dr. Ondria Gleason profile image

Dr. Ondria Gleason

University of Oklahoma

Chief Medical Officer

MD from the University of Oklahoma College of Medicine

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+
Dr. Lindsey A. Criswell profile image

Dr. Lindsey A. Criswell

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Director since 2021

MD, MPH, DSc

Dr. Robert Colbert profile image

Dr. Robert Colbert

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Clinical Director since 2014

MD

Curtis National Hand Center

Collaborator

Trials
1
Recruited
380+

Emory Healthcare

Collaborator

Trials
6
Recruited
1,900+

Ohio State University

Collaborator

Trials
891
Recruited
2,659,000+
Dr. John J. Warner profile image

Dr. John J. Warner

Ohio State University

Chief Executive Officer since 2023

MD, MBA

Dr. Peter Mohler profile image

Dr. Peter Mohler

Ohio State University

Chief Medical Officer since 2023

PhD in Molecular Biology

University of Pittsburgh Medical Center

Collaborator

Trials
78
Recruited
77,600+

Leslie C. Davis

University of Pittsburgh Medical Center

Chief Executive Officer since 2021

BA in Economics from Wesleyan University, MBA in Health Administration from The Wharton School

Don Yealy

University of Pittsburgh Medical Center

Chief Medical Officer since 2023

MD from the Pritzker School of Medicine, University of Chicago

Norton Healthcare

Collaborator

Trials
17
Recruited
2,900+

OrthoCarolina Research Institute, Inc.

Collaborator

Trials
37
Recruited
6,000+

Wake Forest University Health Sciences

Collaborator

Trials
1,432
Recruited
2,506,000+
Dr. L. Ebony Boulware profile image

Dr. L. Ebony Boulware

Wake Forest University Health Sciences

Chief Medical Officer since 2022

MD from Duke University School of Medicine, MPH from Johns Hopkins Bloomberg School of Public Health

Dr. Julie Ann Freischlag profile image

Dr. Julie Ann Freischlag

Wake Forest University Health Sciences

Chief Executive Officer since 2020

BS from University of Illinois, MD from Rush University

Findings from Research

In a study of 278 patients with ulnar nerve entrapment, both surgical techniques (subcutaneous transposition and modified submuscular transposition) showed improvements in nerve function after 2 years, indicating their efficacy in treating this condition.
For patients with more severe grades (II and III), the modified submuscular transposition technique resulted in significantly better outcomes compared to subcutaneous transposition, suggesting it is the preferred method for these cases.
Comparative study of different surgical transposition methods for ulnar nerve entrapment at the elbow.Zhong, W., Zhang, W., Zheng, X., et al.[2017]
In a study of 31 patients who underwent ulnar nerve decompression and anterior transposition, 100% reported satisfaction with the procedure, indicating it is a safe and effective treatment for ulnar nerve compression.
The procedure resulted in significant improvements in symptoms, with 52% of patients reporting no paresthesia post-surgery, demonstrating its efficacy in restoring function and reducing discomfort.
ELBOW ULNAR NEUROPATHY: TREATMENT BY ANTERIOR TRANSPOSITION OF THE ULNAR NERVE.Neder, AT., Alves, RA., Pardini, AG., et al.[2020]
In a study of 41 patients with cubital tunnel syndrome, surgical treatment based on ulnar nerve stability—either simple decompression or anterior transposition—resulted in significant improvements in grip strength, pinch strength, and overall function after 2 years.
Factors such as older age, lower preoperative grip strength, and poorer two-point discrimination were linked to less favorable outcomes, highlighting the importance of these metrics in predicting recovery.
Factors Influencing Outcomes after Ulnar Nerve Stability-Based Surgery for Cubital Tunnel Syndrome: A Prospective Cohort Study.Kang, HJ., Oh, WT., Koh, IH., et al.[2022]

References

Endoscopic decompression of the ulnar nerve at the elbow. [2010]
Comparative study of different surgical transposition methods for ulnar nerve entrapment at the elbow. [2017]
ELBOW ULNAR NEUROPATHY: TREATMENT BY ANTERIOR TRANSPOSITION OF THE ULNAR NERVE. [2020]
Factors Influencing Outcomes after Ulnar Nerve Stability-Based Surgery for Cubital Tunnel Syndrome: A Prospective Cohort Study. [2022]
Prospective randomized controlled study comparing simple decompression versus anterior subcutaneous transposition for idiopathic neuropathy of the ulnar nerve at the elbow: Part 1. [2022]
Surgical treatment for ulnar nerve entrapment at the elbow. [2022]
Techniques for successful management of ulnar nerve entrapment at the elbow. [2022]
Submuscular versus subcutaneous anterior ulnar nerve transposition: a rat histologic study. [2009]